Hindustan Foods Q1 FY27: consolidated PAT +33% YoY to ₹42.8 Cr, margins expand, guidance held

Hindustan Foods posted consolidated revenue of ₹1,201.08 Cr (+17.9% YoY, +7.6% QoQ) and PAT of ₹42.76 Cr (+32.8% YoY on the filing's restated ₹32.21 Cr base, +2.9% QoQ) for Q1 FY27, with EPS at ₹3.53 versus ₹2.70 a year ago. NPM improved to 3.56% from 3.16% YoY, though it eased from 3.72% in Q4 FY26. Neither this quarter nor the year-ago quarter carried an exceptional item, so the YoY comparison is clean at the P&L level — but part of the growth is inorganic: the quarter includes the newly acquired Ultra Beauty Care manufacturing facility at Aurangabad (₹21.81 Cr consideration, acquired April 1, 2026), and the company explicitly flags Q1 FY27 as not comparable to prior periods on this count. Standalone PAT of ₹40.81 Cr (+32.2% YoY) tracks the consolidated growth closely, with no material divergence between the two.

Operating margin was roughly 8.3-8.4% this quarter versus about 7.9-8.0% a year ago (modest YoY expansion) but down from the 8.9-9.3% band in Q4 FY26 — cost of materials consumed rose to ₹964.32 Cr (80% of revenue) and manufacturing/operating costs to ₹72.84 Cr, while finance costs (₹23.40 Cr) and depreciation (₹26.18 Cr) both stepped up as newly added capacity, including the Aurangabad facility, comes onstream and utilization is still ramping.

The stock went into the print at ₹586.85, up 8.1% over the past month of trading.

For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 5 consecutive quarters; revenue is at a 6-quarter high.

Management's press release title itself frames the quarter as 'Reaffirms Guidance' — the FY27 PAT guidance of ₹200-220 Cr given on the May 2026 concall stands, and Q1's ₹42.76 Cr consolidated PAT is about 19-21% of that full-year range, consistent with a back-half-loaded ramp as utilization improves through the year, as management had previously indicated. No quarter-specific street consensus was found; full-year FY27 analyst estimates (Trendlyne) point to roughly 20.5% revenue growth and 35.1% profit growth, against which Q1's 17.9% YoY revenue growth and 32.8% adjusted PAT growth run broadly in line, slightly behind on revenue. Management's own commentary attributes the print to 'robust execution and the continued strength of our diversified manufacturing platform,' tying it to capacity investments across beverages, ice cream and home & personal care — consistent with the quarter's acquisition-led capacity addition.